Depleted Tumor Suppressor miR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer

被引：3
|
作者：
Imamura, Taisuke [1 ]
Komatsu, Shuhei [1 ]
Ichikawa, Daisuke [1 ]
Okajima, Wataru [1 ]
Ohashi, Takuma [1 ]
Kiuchi, Jun [1 ]
Nishibeppu, Keiji [1 ]
Ikoma, Hisashi [1 ]
Taniguchi, Hiroki [1 ]
Otsuji, Eigo [1 ]
机构：
[1] Kyoto Prefectural Univ Medicne, Kyoto Red Cross Hosp 2, Kyoto, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2017年 / 225卷 / 04期
关键词：
D O I：
10.1016/j.jamcollsurg.2017.07.848
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E120 / E120
页数：1
相关论文
共 50 条
  • [21] RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
    Du, Jun
    Xu, Ren
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (12) : 15755 - 15766
  • [22] Plasma microRNA profiles; down-regulation of plasma miR-107 level contributes to poor outcomes in pancreatic cancer
    Imamura, T.
    Komatsu, S.
    Ichikawa, D.
    Miyamae, M.
    Morimura, R.
    Ikoma, H.
    Konishi, H.
    Shiozaki, A.
    Taniguchi, H.
    Otsuji, E.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S117 - S117
  • [23] Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer
    Zhang, Xiao-Fei
    Tu, Rongfu
    Li, Keke
    Ye, Pengxiang
    Cui, Xiaofeng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (10) : 3391 - 3400
  • [24] The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
    Biancur, Douglas E.
    Kimmelman, Alec C.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (01): : 67 - 75
  • [25] Tumor suppressor miRNA-655 in plasma contributes to poor outcomes and is a novel therapeutic target in ESCC
    Kiuchi, Jun
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Imamura, Taisuke
    Nishibeppu, Keiji
    Kosuga, Toshiyuki
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2018, 109 : 466 - 466
  • [26] Tumor suppressor gene PTEN in prostate cancer:: A potential therapeutic target
    Magi-Galluzzi, C
    Skacel, M
    Sercia, L
    García, J
    Reuther, A
    Klein, E
    Dreicer, R
    Zhou, M
    LABORATORY INVESTIGATION, 2006, 86 : 148A - 148A
  • [27] Tumor suppressor gene PTEN in prostate cancer: A potential therapeutic target
    Magi-Galluzzi, C
    Skacel, M
    Sercia, L
    Garcia, J
    Reuther, AM
    Klein, EA
    Dreicer, R
    Zhou, M
    JOURNAL OF UROLOGY, 2006, 175 (04): : 512 - 513
  • [28] Tumor suppressor gene PTEN in prostate cancer: A potential therapeutic target
    Magi-Galluzzi, C
    Skacel, M
    Sercia, L
    Garcia, J
    Reuther, A
    Klein, E
    Dreicer, R
    Zhou, M
    MODERN PATHOLOGY, 2006, 19 : 148A - 148A
  • [29] Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target
    Hartupee, Conner
    Nagalo, Bolni Marius
    Chabu, Chiswili Y.
    Tesfay, Mulu Z.
    Coleman-Barnett, Joycelynn
    West, John T.
    Moaven, Omeed
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [30] NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer
    Han, Ye
    Kuang, Yuting
    Xue, Xiaofeng
    Guo, Xiaobo
    Li, Pu
    Wang, Xu
    Guo, Xingpo
    Yuan, Bin
    Zhi, Qiaoming
    Zhao, Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (05) : 497 - 505
12345